Clinical Trials Logo

Anti-Inflammatory Agents clinical trials

View clinical trials related to Anti-Inflammatory Agents.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03550781 Not yet recruiting - Takayasu Arteritis Clinical Trials

Anti-inflammatory Treatment for Inactive Takayasu Arteritis

ATITA
Start date: June 1, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

Currently, the traditional disease activity of Takayasu arteritis is mainly based on National Institutes of Health criteria and the inactive cases don't need anti-inflammatory treatment. However, pathologic findings showed that there was still inflammatory activity in the affected vessels, and the follow-up data also found significant lesion progression in some inactive cases. Sixty inactive Takayasu arteritis patients will be recruited to determine whether these individuals are active by screening new inflammatory markers in this study. New inflammatory markers included tumor necrosis factor,interleukin-2,interleukin-6,interleukin-8,interleukin-10,high-sensitivity C-reactive protein, and 18f-FDG positron emission tomograph. According to new inflammatory markers, sixty patients will be divided into two categories: inactive patients (n=20) and active patients (n=40). And then, Forty active patients diagnosed by new inflammatory markers will be randomly assigned to either anti-inflammatory therapy group or control group. The changes of inflammatory activity and lesion progression will be observed during one-year follow up in all 60 patients.